By a News Reporter-Staff News Editor at Biotech Week -- Fresh data on Mycobacterium Infections are presented in a new report. According to news reporting from Gujarat, India, by NewsRx journalists, research stated, "Tuberculosis has remained, unambiguously, a significant health care problem since long times, particularly in developing countries. The endeavoring battle against multi drug resistant TB, multiple dosing, their prominent side effects and bioavailability hiccups related to fixed dose combinations has undeniably become a Herculean task indicating rigorous research requirement in anti TB drug therapy."
The news correspondents obtained a quote from the research from the M.S. University of Baroda, "In view of the fact that patenting a drug molecule, a drug delivery system or a formulation has been very fruitful for the growth and sustainment of pharmaceutical industry, a meticulous review of recent developments, providing a balanced view on merits/demerits, will facilitate researchers to update themselves, thereby focusing their research in more relevant areas to furnish desired quality traits. This article reviews the present scenario in terms of drug delivery approaches for TB chemotherapy. The review encompasses and summarizes recent patents and advances on variegated facets of dosage forms, together with from conventional solid oral to novel controlled release oral formulations and additionally alternative weapons for anti TB drug delivery."
According to the news reporters, the research concluded: "A critical review of multidisciplinary approaches to boost anti TB therapy may facilitate the scientists to resolve existing technological gaps."
For more information on this research see: Recent patents and advances on anti - tuberculosis drug delivery and formulations. Recent Patents On Drug Delivery & Formulation, 2013;7(2):138-49 (see also Mycobacterium Infections).
Our news journalists report that additional information may be obtained by contacting C. Vora, Pharmacy Department, Faculty of Technology and Engineering, The MS University of Baroda, Kalabhavan, Vadodara- 390001, Gujarat, India. Additional authors for this research include R. Patadia, K. Mittal and R. Mashru.
Keywords for this news article include: Asia, India, Gujarat, Chemotherapy, Infectious Disease, Drug Delivery Systems, Gram Positive Bacteria, Mycobacterium Infections, Actinomycetales Infections, Mycobacterium Tuberculosis.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC